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Abstract. Background: Zfat is a nuclear protein that
harbours putative DNA-binding domains. T-cell specific
deletion of Zfat in Zfatf/f-CD4Cre mice yields a significant
decrease in the number of peripheral T-cells with a lower
surface expression of interleukin-7 receptor-α (IL-7Rα).
However, the molecular mechanism by which Zfat controls
IL-7Rα expression remains unknown. Materials and
Methods: Expression levels of the molecules involved in IL-
7Rα expression were determined by immunoblotting. Results:
Zfat-deficient peripheral T-cells showed a marked reduction
in the FoxO1 protein that regulates IL-7Rα expression;
however, the FoxO1 mRNA expression level was not affected
by Zfat-deficiency. Furthermore, treatment of Zfat-deficient
T-cells with a proteasome inhibitor, epoxomicin, restored
FoxO1 expression levels, indicating that the loss of Zfat
enhanced the proteasomal degradation of the FoxO1 protein.
Conclusion: These results suggest that Zfat is required for
peripheral T-cell homeostasis through IL-7Rα expression by
controlling the FoxO1 protein. 
Zfat (zinc-finger protein in autoimmune thyroid disease
susceptibility region/zinc-finger protein with AT-hook) is a
nuclear protein that harbours an AT-hook domain and 18-
repeats of the C2H2 zinc-finger motif of which amino acid
sequences are highly conserved from fishes to higher
primates (1, 2). Zfat plays critical roles in early embryonic
development, cell survival and cellular differentiation (3-7).
Zfat was originally identified as a candidate susceptibility
gene for autoimmune thyroid disease (2). In fact, Zfat is
highly expressed in T- and B-cells in immune-related tissues
(1, 8). T-cell-specific deletion of the Zfat gene in mice by
crossing Zfatf/f mice with LckCre mice yields a drastic
reduction in the number of CD4+CD8+ double-positive (DP)
thymocytes (9). Zfat-deficiency in DP thymocytes results in
de-regulated activations of ERK, JNK and p38 MAPKs
implying that Zfat is an essential molecule for the
development and survival of the thymic T-cells probably
through regulation of MAPK signaling pathway (9, 10).
Furthermore, Zfatf/f-CD4Cre mice showed a significant
reduction in the number of both CD4+ and CD8+ T-cells in
the peripheral immune tissues (11). Zfat-deficient peripheral
T-cells exhibited a severe defect in proliferation with an
impaired induction of interleukin-2 receptor-α (IL-2Rα) in
response to T-cell receptor (TCR) stimulation (11).
Furthermore, Zfat-deficient peripheral T-cells showed a
reduced surface expression level of interleukin-7 receptor α
(IL-7Rα) (11). Interleukin-7 (IL-7) is a cytokine, which
plays a pivotal role in the modulation of the homeostasis of
peripheral T-cells (12, 13). The control of IL-7 signaling is
mainly dependent on the surface expression level of IL-7Rα
(14). Therefore, Zfat plays a critical role in the maintenance
of peripheral T-cell homeostasis through regulation of IL-
7Rα expression. However, the molecular mechanism by
which Zfat controls IL-7Rα expression remains unknown.
FoxO1 is a transcription factor of the forkhead box O
(FoxO) family that regulates many cellular processes,
including cell-cycle regulation, cell survival and metabolism
(15). FoxO1 activity is stringently regulated by nutrients,
growth factors and cytokines. In response to these signals,
particular kinases, downstream of phosphatidylinositol-3
kinase phosphorylate FoxO1, result in the translocation of
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FoxO1 from nucleus to cytosol and subsequent to its
proteasomal degradation (16). Several recent studies have
shown an importance of FoxO1 in the immune system,
including peripheral T-cell homeostasis (17). Indeed, FoxO1
controls IL-7Rα mRNA expression by binding to the
regulatory region of the Il7ra gene in T-cells (18, 19).
Herein, we showed that Zfat-deficiency in the peripheral
T-cell results in a drastic decrease in FoxO1 protein
expression. Surprisingly, the FoxO1 mRNA level was not
affected in the Zfatf/f-CD4Cre T-cells. Treatment with a
proteasome inhibitor restored the FoxO1 protein level in the
Zfatf/f-CD4Cre T-cells suggesting a deregulated proteasomal
degradation of FoxO1 in the Zfat-deficient T-cells. These
data imply that Zfat is required for the peripheral T-cell
homeostasis through IL-7Rα expression by controlling
FoxO1 protein. 
Materials and Methods
Antibodies. The following antibodies were purchased from BD
Biosciences (San Jose, CA, USA): CD4 (RM4-5), CD8 (53-6.7), B220
(RA3-6B2), CD44 (IM7) and TCRβ (H57-597). The antibodies used
were as follows: anti-actin (A2066) from Sigma-Aldrich (St. Louis,
MO, USA), anti-FoxO1 (C29H4) and anti-Akt from Cell Signaling
(Danvers, MA, USA), anti-Skp2 from Santa Cruz Biotechnology
(Santa Cruz, CA, USA), anti-FoxP1 from EPITOMICS (Cambridge,
MA, USA) and anti-Mdm2 from Calbiochem (Billerica, MA, USA).
Anti-Zfat antibody was prepared as described previously (1).
Flow cytometry. Cells from spleen and thymus (C57BL/6; CLEA,
Tokyo Japan) were depleted of erythrocytes by hypotonic lysis.
Cells were incubated with specific antibodies in the presence of
2.4G2 antibody (anti-Fcγ receptor; BD Biosciences). Data were
collected with a cytometer (FACSAria II; BD Biosciences) and were
analysed with the FlowJo software (FLOWJO, Ashland, OR, USA).
Cell separation was performed with MACS Cell Separation
Reagents, CD4 MicroBeads, CD8 MicroBeads and B220 (CD45R)
MicroBeads (Miltenyi, San Diego, CA, USA) or by using the cell
sorting function of the FACSAria II.
Quantitative real-time polymerase chain reaction (RT-PCR). Total RNA
was extracted from separated cells using a Qiagen RNeasy kit (Qiagen,
Venio, Netherlands). Quantitative real-time polymerase chain reaction
was performed using a LightCycler FastStart DNA Master SYBR
Green I (Roche, South San Francisco, CA, USA) and ABI PRISM
7900HT Sequence Detection System (Applied Biosystems, Waltham,
MA, USA) as described previously (1, 7). The PCR primers used for
each gene were FoxO1, 5’-CATTCCGTCCATCGGTGTTTC-3’ and 5’-
TCTCATGCAAACCAGGCCTTC-3’; FoxP1, 5’-CATGAACCCGC
ATGCCTCTAC-3’ and 5’-ACAGCCTGGCCACTTGCATAC-3’; and
β-Actin (Actb), 5’-CATCCGTAAAGACCTCTATGCCAAC-3’ and 5’-
ATGGAGCC ACCGATCCACA-3’.
Immunoblotting. Separated cells were lysed in RIPA buffer (50 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS, protease inhibitor cocktail (Roche) and
subjected to immunoblotting, as described previously (1). The
quantitative analysis of the immunoblots was performed using the
integration value of each blot through the measurement module
(BZ-H1M; Keyence, Osaka, Japan). β-Actin intensity was used as a
loading control and the relative intensity of the signal was
normalised by the signal-intensity of protein expression in the
cellular lysate of Zfatf/f mice as 1.
Statistical analysis. The data were presented as the means±standard
deviation (SD). The statistical analyses were performed using an
unpaired two-tailed Student’s t-test. Differences with p<0.05 were
considered statistically significant. 
Results
Marked reduction in the FoxO1 protein levels in the splenic
CD4+ and CD8+ T-cells in Zfatf/f-CD4Cre mice. To address the
molecular mechanisms by which Zfat-deficiency causes a
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Figure 1. Marked reduction in the FoxO1 protein levels in the splenic
CD4+ and CD8+ T-cells in Zfatf/f-CD4Cre mice. Immunoblot of FoxO1
and FoxP1 on the splenic CD4+ T-cells, CD8+ T-cells and B cells (left
panel) and whole thymus (right panel) from Zfatf/f and Zfatf/f-CD4Cre
mice. β-Actin was used as a loading control. Data are representative of
three independent experiments.
Figure 2. mRNA expressions of FoxO1 and FoxP1 are not changed in
Zfat-deficient CD4+ T-cells. Quantitative RT-PCR analysis of FoxO1 and
FoxP1 mRNA expression in the splenic CD4+TCRβ+CD44lo-naive
CD4+ T-cells from Zfatf/f (black bars, n=6) and Zfatf/f-CD4Cre (white
bars, n=9) mice. The relative expression for each gene was normalized
by expression of β-actin (Actb). The data are the mean±standard
deviation of three independent experiments. n.s., Not significant.
reduced surface expression of IL-7Rα, we first examined the
expression levels of FoxO1 and FoxP1, both of which control
the expression of Il7rα mRNA in T-cells (18-20). Remarkably,
the expression level of the FoxO1 protein, but not that of the
FoxP1 protein, was dramatically decreased in splenic CD4+ and
CD8+ T-cells; however, this was not the for case B-cells in
Zfatf/f-CD4Cre mice compared with those in Zfatf/f mice. By
contrast, the levels of FoxO1 and FoxP1 protein expression in
the thymus were comparable between genotypes (Figure 1A).
However, neither the expression of FoxO1 nor FoxP1 mRNA
was affected by Zfat-deficiency in naive CD4+ T-cells (Figure 2).
These data indicate that Zfat-deficiency caused a marked
reduction in FoxO1 protein levels in splenic CD4+ and CD8+ T-
cells without affecting its mRNA expression; this suggested that
a decreased expression of IL-7Rα in Zfat-deficient peripheral T-
cells may result from de-regulation of the FoxO1 protein.
Enhanced proteasomal degradation of FoxO1 in splenic
CD4+ and CD8+ T-cells from Zfatf/f-CD4Cre mice. The
FoxO1 protein level is mainly regulated through proteasomal
degradation (16). Therefore, we next performed an ex vivo
culture of splenic CD4+ and CD8+ T-cells in the presence of
a proteasome inhibitor, epoxomicin. Treatment of T-cells
with epoxomicin drastically restored the FoxO1 protein
levels in the CD4+ and CD8+ T-cells from Zfatf/f-CD4Cre
spleen (Figure 3). Indeed, the FoxO1 protein levels in the
CD4+ T-cells from Zfatf/f-CD4Cre mice that were cultured
with epoxomicin for 6 h were comparable to those in the
Zfatf/f CD4+ T-cells (Figure 3). These results indicated that
the proteasomal degradation of FoxO1 was enhanced in the
peripheral T-cells from Zfatf/f-CD4Cre mice. 
Expression of molecules involved in FoxO1 degradation in
Zfat-deficient T-cells. Proteasomal degradation of FoxO1
requires the ubiquitination by SCF E3 ubiquitin ligase
complex containing Skp2 following Akt-mediated
phosphorylation (21). Therefore, we examined the effect of
Zfat-deficiency on the expression of Skp2 and Akt. However,
analyses of Skp2 and Akt levels did not reveal any differences
between Zfatf/f and Zfatf/f-CD4Cre T-cells (Figure 4). Mdm2 is
also known to be an E3 ubiquitin ligase for FoxO1 (22).
However, the expression level of the Mdm2 protein was
comparable between the genotypes (Figure 4). Finally, we
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Figure 3. Restoration of FoxO1 protein level by a proteasome inhibitor. Immunoblot of FoxO1 on the splenic CD4+ (left) and CD8+ T (right)-cells
from Zfatf/f and Zfatf/f-CD4Cre mice after treatment with a proteasome inhibitor, epoxomicin. β-Actin was used as a loading control. Data are
representative of three independent experiments.
Figure 4. Zfat-deficiency does not affect the expression levels of Skp2,
Akt or Mdm2 protein. Immunoblot of Skp2, Akt and Mdm2 on the
splenic CD4+, CD8+ T-cells and B-cells from Zfatf/f and Zfatf/f-CD4Cre
mice. β-Actin was used as a loading control. Data are representative of
three independent experiments.
Figure 5. No physical interaction of Zfat with FoxO1 or Skp2. Anti-Zfat
or control (Ctl.) IgG immunoprecipitations were performed using the
cell lysates from the thymus or spleen, followed by immunoblotting with
anti-Zfat, anti-FoxO1 or anti-Skp2 antibody.
could not detect any interactions between Zfat and FoxO1 or
Skp2 (Figure 5). These results indicated that ubiquitination or
phosphorylation was not involved in the enhanced proteasomal
degradation of FoxO1 in Zfatf/f-CD4Cre T-cells. Deregulation
of another post-translational modification on FoxO1 protein,
such as methylation and acetylation, may cause deregulated
proteasomal degradation of FoxO1 in Zfat-deficient T-cells. 
Discussion
In this study, we showed that the FoxO1 protein was markedly
reduced in the peripheral T-cells from Zfatf/f-CD4Cre mice.
Zfat-deficiency enhanced the proteasomal degradation of the
FoxO1 protein without affecting the transcription of FoxO1
mRNA. These results indicate that Zfat plays a critical role in
controlling FoxO1 protein expression through the regulation
of proteasomal degradation in peripheral T-cells.
Recent studies have identified several direct FoxO1-target
genes involved in T-cell homeostasis (18, 19). One important
target is Il7ra. FoxO1 regulates the expression of IL-7Rα by
binding to a 3.5 kb upstream region of the transcription start
site of the Il7ra gene (19). Indeed, deletion of FoxO1 gene
in mice causes the loss of IL-7Rα in the peripheral T-cells
(18, 19). Given that IL-7Rα expression is decreased in Zfat-
deficient peripheral T-cells (11), Zfat is an important
molecule for IL-7Rα expression by controlling FoxO1
protein levels in the peripheral T-cells. Furthermore, FoxO1
also directly regulates the expression of the Klf2
transcription factor, which in turn controls the expression of
L-selectin and C-C chemokine receptor type 7 (CCR7) (18,
19). These receptors are important for T-cell homing.
Interestingly, the expression of both L-selectin and CCR7
was decreased in Zfat-deficient naive CD4+ T-cells from
lymph nodes (11). Therefore, Zfat is also involved in the
regulation of peripheral T-cell homing through regulation of
FoxO1. Taken together, Zfat may link survival and homing
of the peripheral T-cells by regulating IL-7Rα, L-selectin and
CCR7 by controlling FoxO1 protein expression.
In conclusion, we demonstrated that Zfat-deficiency in the
peripheral T-cells results in a marked reduction of FoxO1
protein levels due to its enhanced proteasomal degradation,
thus indicating that Zfat is required for the proper maintenance
of peripheral T-cell homeostasis by controlling FoxO1 protein
expression. Therefore, elucidation of the precise molecular
mechanisms by which Zfat regulates FoxO1 degradation will
provide deeper insights into the peripheral T-cell homeostasis. 
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